Skip to main content
Clinical Trials/ITMCTR2200006074
ITMCTR2200006074
Not yet recruiting
Phase 1

A randomized controlled study of improved pelvic sacral moxibustion in the prevention and treatment of primary dysmenorrhea with cold coagulation and blood stasis

The Third Affiliated Hospital of Zhejiang Chinese Medical University0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
primary dysmenorrhea with cold coagulation and blood stasis
Sponsor
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
The Third Affiliated Hospital of Zhejiang Chinese Medical University

Eligibility Criteria

Inclusion Criteria

  • ? Women aged between 18 and 50;
  • ? Regular menstrual cycle (21±7 days);
  • ? Color ultrasound and gynecological examination showed no organic disease;
  • ? Dysmenorrhea VAS (visual analog score) \>40 at the time of inclusion
  • ? In the menstrual cycle prior to this treatment, no other treatment was received, and no analgesics, sedatives or hormone drugs were taken;
  • ? Nearly half a year without pregnancy plan;
  • ? The patients voluntarily participate and sign the informed consent.

Exclusion Criteria

  • ? Breast\-feeding women;
  • ? Those who suffer from other serious systemic diseases, such as cardiovascular diseases and malignant tumors, and those who are considered unsuitable for the study by the researcher;
  • ? Those who are currently undergoing other treatments (drug or non\-drug), which may affect the measurement of effect indicators in this study;
  • ? Do not cooperate with treatment plan arrangement;
  • ? Fever or other factors resulting in abnormal body temperature;
  • ? Superficial sensory disorders;
  • ? People who are allergic to ginger or alcohol.

Outcomes

Primary Outcomes

Not specified

Similar Trials